美国 · 平台与数据 · Benzinga
Helus Pharma Touts Positive Data for Depression Drug

详细摘要
Helus Pharma Inc. (NASDAQ:HELP) reported topline results from its pivotal Phase 3 APPROACH trial, showing its novel serotonergic agonist HLP003 rapidly and durably reduced…
MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.benzinga.com)




